Boosting immune cell memory to improve vaccines and cancer immunotherapy

Drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells, studies on mice show. This approach could be used to improve how well vaccines and immunotherapies work and how long they last.